Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions
- 837 Downloads
In this study, the potential contribution of Dixon-based MR imaging with a rapid low-resolution breath-hold sequence, which is a technique used for MR-based attenuation correction (AC) for MR/positron emission tomography (PET), was evaluated for anatomical correlation of PET-positive lesions on a 3T clinical scanner compared to low-dose CT. This technique is also used in a recently installed fully integrated whole-body MR/PET system.
Thirty-five patients routinely scheduled for oncological staging underwent 18F-fluorodeoxyglucose (FDG) PET/CT and a 2-point Dixon 3-D volumetric interpolated breath-hold examination (VIBE) T1-weighted MR sequence on the same day. Two PET data sets reconstructed using attenuation maps from low-dose CT (PETAC_CT) or simulated MR-based segmentation (PETAC_MR) were evaluated for focal PET-positive lesions. The certainty for the correlation with anatomical structures was judged in the low-dose CT and Dixon-based MRI on a 4-point scale (0–3). In addition, the standardized uptake values (SUVs) for PETAC_CT and PETAC_MR were compared.
Statistically, no significant difference could be found concerning anatomical localization for all 81 PET-positive lesions in low-dose CT compared to Dixon-based MR (mean 2.51 ± 0.85 and 2.37 ± 0.87, respectively; p = 0.1909). CT tended to be superior for small lymph nodes, bone metastases and pulmonary nodules, while Dixon-based MR proved advantageous for soft tissue pathologies like head/neck tumours and liver metastases. For the PETAC_CT- and PETAC_MR-based SUVs (mean 6.36 ± 4.47 and 6.31 ± 4.52, respectively) a nearly complete concordance with a highly significant correlation was found (r = 0.9975, p < 0.0001).
Dixon-based MR imaging for MR AC allows for anatomical allocation of PET-positive lesions similar to low-dose CT in conventional PET/CT. Thus, this approach appears to be useful for future MR/PET for body regions not fully covered by diagnostic MRI due to potential time constraints.
KeywordsAttenuation correction Dixon-based VIBE T1-weighted MR sequence Localization Low-dose CT MR/PET
We thank Brigitte Dzewas and Sylvia Schachoff and the whole PET team for their excellent technical assistance.
Conflicts of interest
- 12.Beer AJ, Eiber M, Souvatzoglou M, Holzapfel K, Ganter C, Weirich G, et al. Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer. Mol Imaging Biol 2011;13:352–61.PubMedCrossRefGoogle Scholar
- 15.Catana A, Van Der Kouwe A, Benner T, Hamm M, Michel C, Fischl B, et al. Is accurate bone segmentation required for MR-based PET attenuation correction? Proc Int Soc Magn Reson Med 2009:593.Google Scholar
- 17.Keereman V, De Deene Y, Lemahieu I, Vandenberghe S. Estimation of attenuation maps from UTE derived R2 image. Proc Int Soc Magn Reson Med 2009:2774.Google Scholar
- 31.Ng S, Yen T, Chang JT, Chan S, Ko S, Wang H, et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 2006;24:4371–6.PubMedCrossRefGoogle Scholar